COX-2: A target for colon cancer prevention

被引：256
|
作者：
Marnett, LJ
DuBois, RN
机构：
[1] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Ctr Mol Toxicol,Dept Biochem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Ctr Mol Toxicol,Dept Chem, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Ctr Mol Toxicol,Dept Med, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Ctr Mol Toxicol,Dept Cell Biol, Nashville, TN 37232 USA
[5] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37232 USA
来源：
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY | 2002年 / 42卷
关键词：
cyclooxygenase; prostaglandins; NSAIDs; cancer; prevention;
D O I：
10.1146/annurev.pharmtox.42.082301.164620
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Disease prevention is one area that both public and governmental agencies strongly support owing to its potential for an improved lifestyle and a reduction in health care costs. In this review, we focus on the clinical development of one target for cancer prevention, the COX-2 enzyme. This provides an excellent example of how basic research in biochemistry and pharmacology can lead to translational studies and eventually to approval of a drug by the FDA for use as a chemopreventive agent in humans. It is hoped that, as the genome sequence: is understood more clearly, other targets will emerge that will provide even more effective drugs for future cancer prevention.
引用
收藏
页码：55 / +
页数：26
相关论文
共 50 条
  • [21] COX-2 inhibitors for the prevention of breast cancer
    Howe, LR
    Dannenberg, AJ
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2003, 8 (01) : 31 - 43
  • [22] Targeting COX-2 for cancer prevention and therapy
    Marnett, Lawrence J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [23] COX-2 inhibition and the prevention of gastric cancer
    Lee, Dong-Soo
    Moss, Steven F.
    DIGESTION, 2006, 74 (3-4) : 184 - 186
  • [24] COX-2 and colon cancer: Potential targets for chemoprevention
    Fournier, DB
    Gordon, GB
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2000, : 97 - 102
  • [25] Cox-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells
    Agarwal, B
    Swaroop, P
    Protiva, P
    Raj, SV
    Shirin, H
    Holt, PR
    APOPTOSIS, 2003, 8 (06) : 649 - 654
  • [26] Cox-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells
    B. Agarwal
    P. Swaroop
    P. Protiva
    S. V. Raj
    H. Shirin
    P. R. Holt
    Apoptosis, 2003, 8 : 649 - 654
  • [27] COX-2 inhibitors: cancer prevention or cardiovascular risk?
    Senior, K
    LANCET ONCOLOGY, 2005, 6 (02): : 68 - 68
  • [28] COX-2 inhibitors still eyed for cancer prevention
    Thompson, CA
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (09) : 890 - +
  • [29] NSAIDs and cancer prevention: Targets downstream of COX-2
    Cha, Yong I.
    DuBois, Raymond N.
    ANNUAL REVIEW OF MEDICINE, 2007, 58 : 239 - 252
  • [30] COX-2, inflammatory mediators, and cancer prevention.
    DuBois, RN
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2787S - 2787S
12345